🔎 Trials Near Me

Utama › Glioma Pontin Intrinsik Difus › Massachusetts

Kajian klinikal Glioma Pontin Intrinsik Difus di Massachusetts

9 kajian untuk Glioma Pontin Intrinsik Difus sedang mencari peserta di lokasi di Massachusetts.

Bandar di Massachusetts

Teks kajian rasmi (Bahasa Inggeris)

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 11 Sep 2026 · NCT04870944

Targeted Pediatric High-Grade Glioma Therapy

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaKajian pemerhatian
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Susan Chi, Boston
Mengambil pesertaFasa 2
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
Umur 3 hingga 39 · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT05096481

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
Umur 1 hingga 21 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06333899

Combination Therapy for the Treatment of Diffuse Midline Gliomas

  • Dana-Farber Cancer Institute Harvard University, Boston
Mengambil pesertaFasa 2
Umur 2 hingga 39 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT05009992

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
12 Months – 39 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05843253

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa awal 1
Sehingga umur 21 · Semua jantina · Dikemas kini 18 Mac 2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
Mengambil pesertaFasa 1
12 Months – 18 Years · Semua jantina · Dikemas kini 17 Mac 2026 · NCT04943848

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.